1. Home
  2. NKTX vs SVCO Comparison

NKTX vs SVCO Comparison

Compare NKTX & SVCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • SVCO
  • Stock Information
  • Founded
  • NKTX 2015
  • SVCO 1984
  • Country
  • NKTX United States
  • SVCO United States
  • Employees
  • NKTX N/A
  • SVCO N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • SVCO
  • Sector
  • NKTX Health Care
  • SVCO
  • Exchange
  • NKTX Nasdaq
  • SVCO NYSE
  • Market Cap
  • NKTX 123.5M
  • SVCO 140.5M
  • IPO Year
  • NKTX 2020
  • SVCO 2024
  • Fundamental
  • Price
  • NKTX $1.80
  • SVCO $4.95
  • Analyst Decision
  • NKTX Strong Buy
  • SVCO Strong Buy
  • Analyst Count
  • NKTX 6
  • SVCO 5
  • Target Price
  • NKTX $14.40
  • SVCO $17.00
  • AVG Volume (30 Days)
  • NKTX 434.5K
  • SVCO 104.4K
  • Earning Date
  • NKTX 08-12-2025
  • SVCO 08-06-2025
  • Dividend Yield
  • NKTX N/A
  • SVCO N/A
  • EPS Growth
  • NKTX N/A
  • SVCO N/A
  • EPS
  • NKTX N/A
  • SVCO N/A
  • Revenue
  • NKTX N/A
  • SVCO $57,883,000.00
  • Revenue This Year
  • NKTX N/A
  • SVCO $14.25
  • Revenue Next Year
  • NKTX N/A
  • SVCO $15.85
  • P/E Ratio
  • NKTX N/A
  • SVCO N/A
  • Revenue Growth
  • NKTX N/A
  • SVCO 3.65
  • 52 Week Low
  • NKTX $1.31
  • SVCO $3.55
  • 52 Week High
  • NKTX $8.23
  • SVCO $20.69
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 51.45
  • SVCO N/A
  • Support Level
  • NKTX $1.68
  • SVCO N/A
  • Resistance Level
  • NKTX $1.84
  • SVCO N/A
  • Average True Range (ATR)
  • NKTX 0.08
  • SVCO 0.00
  • MACD
  • NKTX 0.01
  • SVCO 0.00
  • Stochastic Oscillator
  • NKTX 80.95
  • SVCO 0.00

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About SVCO SILVACO GROUP INC

Silvaco Group Inc is a provider of technology computer aided design (TCAD) software, electronic data automation (EDA) software and semiconductor intellectual property (SIP). TCAD, EDA and SIP solutions enable semiconductor and photonics companies to increase productivity, accelerate their products' time-to-market and reduce their development and manufacturing costs. It is developing the technology behind the chip and providing solutions that span from atoms to systems, starting with providing software for the atomic level simulation of semiconductor and photonics material for devices, to providing software and SIP for the design and analysis of circuits and system level solutions.

Share on Social Networks: